宫颈癌筛查率因HPV疫苗接种状态而异:一项 interim 分析
该研究基于日本丰中市和磐城市2015财年20岁女性宫颈癌筛查调查数据,比较已接种与未接种HPV疫苗女性的筛查率。2727名1995财年出生女性中HPV疫苗接种率为64.2%(1753/2727),接种者筛查率为6.4%(112/1753),未接种者为3.9%(38/974),差异有统计学意义(p < 0.01)。结论提示接种HPV疫苗的女性更可能获得未来宫颈癌的有效保护。
要点
- 1995财年出生女性HPV疫苗接种率为64.2%(1753/2727)。
- 接种者宫颈癌筛查率6.4%(112/1753),未接种者3.9%(38/974)。
- 两组筛查率差异有统计学意义(p < 0.01)。
核心结论
- HPV疫苗接种女性倾向于比未接种女性更有效地受到未来宫颈癌的保护。
研究设计与样本
- 基于日本丰中市和磐城市2015财年20岁女性宫颈癌筛查调查数据的 interim 分析。
- 纳入1995财年出生、2015财年满20岁并接受宫颈癌筛查目标的2727名女性。
主要发现
- 2727名女性中HPV疫苗接种率为64.2%(1753/2727)。
- 接种者宫颈癌筛查率为6.4%(112/1753),未接种者为3.9%(38/974)。
- 接种者与未接种者筛查率差异有统计学意义(p < 0.01)。
临床怎么用
- 应关注HPV疫苗接种状态与宫颈癌筛查参与率之间的差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The incidence of cervical cancer has been increasing, especially in younger generation, in Japan. The females born between 1994 and 1999, who achieved rates of HPV vaccination approaching 70%, have become the target of cervical cancer screening programs. Here, we have analyzed the cervical cancer screening rates among the vaccinated and unvaccinated women. METHODS: The survey data for cervical cancer screening at age 20 in FY 2015 was derived from two cities, Toyonaka and Iwaki. RESULTS: Among 2,727 females, in Toyonaka and Iwaki, who were born in FY 1995 and targeted in FY 2015 at age 20 for cervical cancer screening, their HPV vaccination rate was 64.2% (1,753/2,727). The screening rate was 6.4% (112/1,753) in the vaccinated and 3.9% (38/974) in the unvaccinated. This difference was statistically significant (p < 0.01). CONCLUSIONS: We have demonstrated that HPV-vaccinated females tended to be effectively protected from future cervical cancer than the unvaccinated.
引用
- Taniguchi M, Ueda Y, Yagi A, et al. Cervical cancer screening rate differs by HPV vaccination status: An interim analysis. Vaccine. 2019. PMID: 31272873. doi:10.1016/j.vaccine.2019.06.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。